Dapansutrile preserves pancreatic beta‐cell function by regulating insulin vesicle membrane fusion and mitochondrial homeostasis | Synapse
March 3, 2026
Dapansutrile preserves pancreatic beta‐cell function by regulating insulin vesicle membrane fusion and mitochondrial homeostasis
Key Points
Preserving pancreatic beta-cell function is crucial for effective diabetes management, and dapansutrile plays a significant role.
The treatment directly targets the NLRP3 inflammasome, which impacts beta-cell performance and health.
Analysis reveals that mitochondrial homeostasis is maintained by dapansutrile, critical to regulating insulin vesicle fusion.
These findings highlight potential avenues for diabetes management strategies, emphasizing the need for further research into this treatment.
Abstract
DAPA targets the NLRP3 inflammasome in pancreatic beta cells of diabetic mice to preserve function, maintain mitochondrial homeostasis and offer potential avenues for diabetes management strategies.